Flortaucipir (18F) PET Imaging in the BIOCARD Study
Phase of Trial: Phase I
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Flortaucipir F 18 (Primary)
- Indications Cognition disorders
- Focus Diagnostic use
- Sponsors Avid Radiopharmaceuticals
- 13 Apr 2017 Status changed from not yet recruiting to recruiting.
- 06 Mar 2017 Planned initiation date changed from 15 Feb 2017 to 1 Mar 2017.
- 17 Feb 2017 New trial record